Workforce expansion authorized after the 2024 Harlem outbreak remains incomplete, with 35 staff onboard versus a planned 56, leaving gaps in inspection and response throughput. A second lethal cluster ...

The FDA's Pharmacy Compounding Advisory Committee met July 23-24 to consider whether 7 unapproved peptides—BPC-157, KPV, TB-500, MOTS-c, emideltide, epitalon, and semax—should be added to the agency's ...

Dermatology offices spend ~13 hours weekly on prior authorizations, file ~39 requests per physician annually, and see roughly one-third denied, creating operational costs and delayed initiation of ...

Mean LDL-C at 6 months was 76.3 vs 85.6 mg/dL, yielding an adjusted difference of −6.62 mg/dL and higher attainment of LDL-C <50 mg/dL. Intervention uptake increased intensive and combination ...

Justin Balko, PharmD, PhD, explains why residual disease in triple-negative breast cancer signals a biology gap, and what ADC trials and cell-free DNA monitoring may reveal. Patients with stage 2 and ...

Dry eye is a multifactorial disease characterized by a loss of homeostasis of the tear film layer, which can present itself in different ways. Dry Eye Awareness Month is dedicated ...

Subcutaneous checkpoint inhibitors drove up volume and forced staffing changes, according to Angie Maynard, PharmD, MS, and ...

Urs Weber, MD, discusses why comprehensive NGS is critical and where community biomarker testing often falls short.

As the number of actionable biomarkers in thoracic oncology continues to grow, the role of the multidisciplinary care team evolves to ensure patients receive comprehensive biomarker testing and ...

David Zhang, MD, discusses the limitations of polygenic risk scores and remaining barriers to their clinical use in idiopathic pulmonary fibrosis. Polygenic risk scores (PRS) may serve as an important ...

A multiyear “tariff cliff” sets 0% through July 2028, then 100% for one year and 200% thereafter, explicitly tying penalties to failure to establish US manufacturing capacity. Sparse implementation ...

The study assessed the impact of Control-IQ technology—an automated insulin delivery (AID) therapy—on the HEDIS-recommended ...